f | { | f | { |
| "author": "", | | "author": "", |
| "author_email": "", | | "author_email": "", |
| "creator_user_id": "0124c449-4279-4839-a7e2-f7ee873dbc7c", | | "creator_user_id": "0124c449-4279-4839-a7e2-f7ee873dbc7c", |
| "groups": [ | | "groups": [ |
| { | | { |
| "description": "Group for publications", | | "description": "Group for publications", |
| "display_name": "Publication", | | "display_name": "Publication", |
| "id": "816c3c41-f871-427d-9e26-fb21e6b3c578", | | "id": "816c3c41-f871-427d-9e26-fb21e6b3c578", |
| "image_display_url": | | "image_display_url": |
| mw/uploads/group/2022-03-17-123757.433896243660articlesquareicon.png", | | mw/uploads/group/2022-03-17-123757.433896243660articlesquareicon.png", |
| "name": "publication", | | "name": "publication", |
| "title": "Publication" | | "title": "Publication" |
| } | | } |
| ], | | ], |
| "id": "21b482cd-b177-4592-93c5-df7de35f899d", | | "id": "21b482cd-b177-4592-93c5-df7de35f899d", |
| "isopen": false, | | "isopen": false, |
| "license_id": "notspecified", | | "license_id": "notspecified", |
| "license_title": "License not specified", | | "license_title": "License not specified", |
| "maintainer": null, | | "maintainer": null, |
| "maintainer_email": null, | | "maintainer_email": null, |
| "metadata_created": "2021-09-16T08:11:53.301004", | | "metadata_created": "2021-09-16T08:11:53.301004", |
n | "metadata_modified": "2022-04-27T03:46:47.110976", | n | "metadata_modified": "2022-04-27T03:51:32.906058", |
| "name": "malawi-integrated-hiv-program-report-2011-q4", | | "name": "malawi-integrated-hiv-program-report-2011-q4", |
| "notes": "This is the second quarterly HIV Program report after | | "notes": "This is the second quarterly HIV Program report after |
| implementation of the 2011 Integrated Clinical HIV Guidelines1 in July | | implementation of the 2011 Integrated Clinical HIV Guidelines1 in July |
| 2011. A summary of the key achievements between October and December | | 2011. A summary of the key achievements between October and December |
| 2011 is provided below:\r\n\r\n* Scale-up of integrated HIV services | | 2011 is provided below:\r\n\r\n* Scale-up of integrated HIV services |
| had reached the following number of sites:\r\n\r\n __806__ HTC | | had reached the following number of sites:\r\n\r\n __806__ HTC |
| sites (565 within and 241 outside of health facilities)\r\n\r\n | | sites (565 within and 241 outside of health facilities)\r\n\r\n |
| __554__ (static) ART sites\r\n\r\n __479__ PMTCT sites (Option | | __554__ (static) ART sites\r\n\r\n __479__ PMTCT sites (Option |
| B+)\r\n\r\n __402__ Pre-ART sites\r\n\r\n __401__ sites with | | B+)\r\n\r\n __402__ Pre-ART sites\r\n\r\n __401__ sites with |
n | HIV-exposed child follow-up\r\n\r\n* 299,017 persons tested and | n | HIV-exposed child follow-up\r\n\r\n* __299,017__ persons tested and |
| counselled for HIV and 29,745 (10%) were HIV positive; 129,928 (43%) | | counselled for HIV and __29,745 (10%)__ were HIV positive; __129,928 |
| people tested for the first time.\r\n\r\n* 134,909 (81%) of 166,697 | | (43%)__ people tested for the first time.\r\n\r\n* __134,909 (81%)__ |
| | | of __166,697__ women at ANC had their HIV status ascertained; __11,350 |
| | | (8%)__ of these were HIV positive and __8,695 (77%)__ of these |
| | | received ARVs. \r\n\r\n* __108,660 (86%)__ of __126,273__ women at |
| women at ANC had their HIV status ascertained; 11,350 (8%) of these | | maternity had their HIV status ascertained; __9,397 (9%)__ of these |
| were HIV positive and 8,695 (77%) of these received ARVs. \r\n\r\n* | | were HIV positive and __7,830 (83%)__ of these received ARVs during |
| 108,660 (86%) of 126,273 women at maternity had their HIV status | | labour. \r\n\r\n* __8,455 (8%)__ of infants discharged alive from |
| ascertained; 9,397 (9%) of these were HIV positive and 7,830 (83%) of | | maternity were known to be HIV exposed, __7,808 (92%)__ of these |
| these received ARVs during labour. \r\n\r\n* 8,455 (8%) of infants | | |
| discharged alive from maternity were known to be HIV exposed, 7,808 | | |
| (92%) of these received ARV prophylaxis. 14,017 women started ART | | received ARV prophylaxis. __14,017__ women started ART under Option |
| under Option B+: 7,218 (51%) were pregnant and 6,799 (49%) were | | B+: __7,218 (51%)__ were pregnant and __6,799 (49%)__ were |
| breastfeeding. \r\n\r\n* 34,727 patients started ART during this | | breastfeeding. \r\n\r\n* __34,727__ patients started ART during this |
| quarter; this represents almost a doubling of the quarterly number of | | quarter; this represents almost a doubling of the quarterly number of |
| ART initiations compared with the period before implementation of the | | ART initiations compared with the period before implementation of the |
| 2011 guidelines. 78% of adults and 77% of children were retained alive | | 2011 guidelines. 78% of adults and 77% of children were retained alive |
t | on ART 12 months after ART initiation. \r\n\r\n* 323,638 patients were | t | on ART 12 months after ART initiation. \r\n\r\n* __323,638__ patients |
| alive and on ART by end of December 2011; 25,161 (8%) were on ART | | were alive and on ART by end of December 2011; __25,161 (8%)__ were on |
| regimen 5A (tenofovir / lamivudine / efavirenz) \r\n\r\n* __10,865__ | | ART regimen 5A (tenofovir / lamivudine / efavirenz) \r\n\r\n* |
| HIV exposed children and __14,609__ pre-ART patients enrolled for | | __10,865__ HIV exposed children and __14,609__ pre-ART patients |
| follow-up in HIV Care Clinics (HCC) \r\n\r\n* __839__ health workers | | enrolled for follow-up in HIV Care Clinics (HCC) \r\n\r\n* __839__ |
| were trained in the new integrated PMTCT/ART curriculum during Q4, | | health workers were trained in the new integrated PMTCT/ART curriculum |
| bringing the total number of health workers re-trained in the new | | during Q4, bringing the total number of health workers re-trained in |
| guidelines to 4,205. The HIV Clinical Mentoring Program was launched | | the new guidelines to 4,205. The HIV Clinical Mentoring Program was |
| with the initial training of 306 mentors during Q4 2011. All training | | launched with the initial training of 306 mentors during Q4 2011. All |
| details were captured in the new national HIV training data base | | training details were captured in the new national HIV training data |
| (TrainSMART) at MOH. \r\n\r\n* __105__ new HTC providers were trained | | base (TrainSMART) at MOH. \r\n\r\n* __105__ new HTC providers were |
| during Q4 and 99 passed their exit exam and qualified as HTC | | trained during Q4 and 99 passed their exit exam and qualified as HTC |
| providers.", | | providers.", |
| "num_resources": 1, | | "num_resources": 1, |
| "num_tags": 1, | | "num_tags": 1, |
| "organization": { | | "organization": { |
| "approval_status": "approved", | | "approval_status": "approved", |
| "created": "2021-10-14T11:02:35.234558", | | "created": "2021-10-14T11:02:35.234558", |
| "description": "The Department of HIV & AIDS (DHA) was established | | "description": "The Department of HIV & AIDS (DHA) was established |
| in 2001, initially as a unit in the Department of Clinical Services, | | in 2001, initially as a unit in the Department of Clinical Services, |
| to coordinate the biomedical HIV Program in Malawi. The department now | | to coordinate the biomedical HIV Program in Malawi. The department now |
| carries responsibility for various HIV related programs including: | | carries responsibility for various HIV related programs including: |
| sexually transmitted infections (STIs), prevention of mother to child | | sexually transmitted infections (STIs), prevention of mother to child |
| transmission of HIV (PMTCT), and national voluntary male medical | | transmission of HIV (PMTCT), and national voluntary male medical |
| circumcision program (VMMC). All these HIV program sub-sections are | | circumcision program (VMMC). All these HIV program sub-sections are |
| linked to one robust monitoring and evaluation sub-section in the HIV | | linked to one robust monitoring and evaluation sub-section in the HIV |
| and AIDS Department which technically operates under the Central | | and AIDS Department which technically operates under the Central |
| Monitoring and Evaluation Department (CMED) of the Ministry of | | Monitoring and Evaluation Department (CMED) of the Ministry of |
| Health.", | | Health.", |
| "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | | "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", |
| "image_url": | | "image_url": |
| 2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg", | | 2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg", |
| "is_organization": true, | | "is_organization": true, |
| "name": "dha", | | "name": "dha", |
| "state": "active", | | "state": "active", |
| "title": "Department of HIV & AIDS and Viral Hepatitis", | | "title": "Department of HIV & AIDS and Viral Hepatitis", |
| "type": "organization" | | "type": "organization" |
| }, | | }, |
| "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | | "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", |
| "private": false, | | "private": false, |
| "program_area": "Care and Treatment", | | "program_area": "Care and Treatment", |
| "relationships_as_object": [], | | "relationships_as_object": [], |
| "relationships_as_subject": [], | | "relationships_as_subject": [], |
| "resources": [ | | "resources": [ |
| { | | { |
| "cache_last_updated": null, | | "cache_last_updated": null, |
| "cache_url": null, | | "cache_url": null, |
| "created": "2022-03-23T19:55:44.757990", | | "created": "2022-03-23T19:55:44.757990", |
| "description": "", | | "description": "", |
| "format": "PDF", | | "format": "PDF", |
| "hash": "", | | "hash": "", |
| "id": "674b5d82-ceeb-4779-8992-45f48c0c460d", | | "id": "674b5d82-ceeb-4779-8992-45f48c0c460d", |
| "last_modified": "2022-04-05T01:01:52.439571", | | "last_modified": "2022-04-05T01:01:52.439571", |
| "lfs_prefix": | | "lfs_prefix": |
| "dha/malawi-integrated-hiv-program-report-2011-q4", | | "dha/malawi-integrated-hiv-program-report-2011-q4", |
| "metadata_modified": "2022-04-05T01:01:52.462207", | | "metadata_modified": "2022-04-05T01:01:52.462207", |
| "mimetype": "application/pdf", | | "mimetype": "application/pdf", |
| "mimetype_inner": null, | | "mimetype_inner": null, |
| "name": "malawi-integrated-hiv-program-report-2011-q4", | | "name": "malawi-integrated-hiv-program-report-2011-q4", |
| "package_id": "21b482cd-b177-4592-93c5-df7de35f899d", | | "package_id": "21b482cd-b177-4592-93c5-df7de35f899d", |
| "position": 0, | | "position": 0, |
| "resource_type": null, | | "resource_type": null, |
| "sha256": | | "sha256": |
| "b32a0c28fedf8b5fb0a1d1223d2b6be94a63f1761e5723429b172105fd18f45d", | | "b32a0c28fedf8b5fb0a1d1223d2b6be94a63f1761e5723429b172105fd18f45d", |
| "size": 1177105, | | "size": 1177105, |
| "state": "active", | | "state": "active", |
| "url": | | "url": |
| f48c0c460d/download/malawi-integrated-hiv-program-report-2011-q4.pdf", | | f48c0c460d/download/malawi-integrated-hiv-program-report-2011-q4.pdf", |
| "url_type": "upload" | | "url_type": "upload" |
| } | | } |
| ], | | ], |
| "state": "active", | | "state": "active", |
| "tags": [ | | "tags": [ |
| { | | { |
| "display_name": "Report", | | "display_name": "Report", |
| "id": "37e5a5df-a993-4d3f-8c9c-73c418c30f0f", | | "id": "37e5a5df-a993-4d3f-8c9c-73c418c30f0f", |
| "name": "Report", | | "name": "Report", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| } | | } |
| ], | | ], |
| "title": "Malawi Integrated HIV Program Report 2011 Q4", | | "title": "Malawi Integrated HIV Program Report 2011 Q4", |
| "type": "dataset", | | "type": "dataset", |
| "url": null, | | "url": null, |
| "version": null, | | "version": null, |
| "year": "2011" | | "year": "2011" |
| } | | } |